3DB8 | pdb_00003db8

Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 041


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.15 Å
  • R-Value Free: 
    0.274 (Depositor), 0.272 (DCC) 
  • R-Value Work: 
    0.226 (Depositor), 0.220 (DCC) 
  • R-Value Observed: 
    0.232 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3DB8

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.

Hanan, E.J.Fucini, R.V.Romanowski, M.J.Elling, R.A.Lew, W.Purkey, H.E.VanderPorten, E.C.Yang, W.

(2008) Bioorg Med Chem Lett 18: 5186-5189

  • DOI: https://doi.org/10.1016/j.bmcl.2008.08.091
  • Primary Citation Related Structures: 
    3DB8

  • PubMed Abstract: 

    A series of 2-amino-isoxazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors. Key SAR and crystallographic data are discussed. More advanced analogues inhibit Plk1 with good enzymatic activity and modest cell-based activity. Differential selectivity among the three Plk isoforms is observed.


  • Organizational Affiliation
    • Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard Suite 400, South San Francisco, CA 94080, USA. info@sunesis.com

Macromolecule Content 

  • Total Structure Weight: 36.4 kDa 
  • Atom Count: 2,110 
  • Modeled Residue Count: 261 
  • Deposited Residue Count: 317 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Polo-like kinase 1317Danio rerioMutation(s): 1 
Gene Names: plk1
EC: 2.7.11.21
UniProt
Find proteins for Q4KMI8 (Danio rerio)
Explore Q4KMI8 
Go to UniProtKB:  Q4KMI8
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ4KMI8
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
1FR

Query on 1FR



Download:Ideal Coordinates CCD File
B [auth A]3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol
C23 H22 Cl N3 O2
MMGKIHLBFPJYJL-HNNXBMFYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.15 Å
  • R-Value Free:  0.274 (Depositor), 0.272 (DCC) 
  • R-Value Work:  0.226 (Depositor), 0.220 (DCC) 
  • R-Value Observed: 0.232 (Depositor) 
Space Group: I 2 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 135.118α = 90
b = 135.118β = 90
c = 135.118γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
ADSCdata collection
MOSFLMdata reduction
SCALAdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-10-07
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-10-20
    Changes: Database references, Derived calculations
  • Version 1.3: 2023-08-30
    Changes: Data collection, Refinement description